The effects of volatile aromatic anesthetics on voltage-gated Na+ channels expressed in xenopus oocytes

Anesthesia and Analgesia

Volumn 107, Issue 5, 2008, Pages 1579-1586

  Horishita, Takafumi ^a   Eger, Edmond I ^b   Harris, R Adron ^a  

^a UNIVERSITY OF TEXAS AT AUSTIN   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1,2 DIFLUOROBENZENE; 1,2,4 TRIFLUOROBENZENE; 1,3,5 TRIFLUOROBENZENE; 1,4 DIFLUOROBENZENE; 4 AMINOBUTYRIC ACID A RECEPTOR; BENZENE; FLUOROBENZENE; HEXAFLUOROBENZENE; INHALATION ANESTHETIC AGENT; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; PENTAFLUOROBENZENE; UNCLASSIFIED DRUG; VOLTAGE GATED SODIUM CHANNEL; 1,2-DIFLUOROBENZENE; ANESTHETIC AGENT; FLUOROCARBON; SODIUM CHANNEL;

ARTICLE; CONTROLLED STUDY; DEPOLARIZATION; FEMALE; INHIBITION KINETICS; LIPID SOLUBILITY; NONHUMAN; OOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; VOLTAGE CLAMP; XENOPUS; ANIMAL; CELL MEMBRANE POTENTIAL; CHANNEL GATING; DRUG EFFECT; GENETICS; PHYSIOLOGY;

ANESTHETICS; ANIMALS; BENZENE; FEMALE; FLUOROBENZENES; FLUOROCARBONS; ION CHANNEL GATING; MEMBRANE POTENTIALS; OOCYTES; RECEPTORS, GABA-A; RECEPTORS, N-METHYL-D-ASPARTATE; SODIUM CHANNELS; XENOPUS;

EID: 56149097547     PISSN: 00032999     EISSN: None     Source Type: Journal    
DOI: 10.1213/ane.0b013e318184b966     Document Type: Article

References (26)

1. Franks NP, Lieb WR. Molecular and cellular mechanisms of general anaesthesia. Nature 1994;367:607-14
2. Ratnakumari L, Hemmings HC Jr. Inhibition of presynaptic sodium channels by halothane. Anesthesiology 1998;88:1043-54
3. Ouyang W, Wang G, Hemmings HC Jr. Isoflurane and propofol inhibit voltage-gated sodium channels in isolated rat neurohypophysial nerve terminals. Mol Pharmacol 2003;64:373-81
4. Rehberg B, Xiao YH, Duch DS. Central nervous system sodium channels are significantly suppressed at clinical concentrations of volatile anesthetics. Anesthesiology 1996;84:1223-33
5. Shiraishi M, Harris RA. Effects of alcohols and anesthetics on recombinant voltage-gated Na- channels. J Pharmacol Exp Ther 2004;309:987-94
6. Ouyang W, Hemmings HC Jr. Isoform-selective effects of isoflurane on voltage-gated Na- channels. Anesthesiology 2007;107: 91-8
7. Schlame M, Hemmings HC Jr. Inhibition by volatile anesthetics of endogenous glutamate release from synaptosomes by a presynaptic mechanism. Anesthesiology 1995;82:1406-16
8. Lingamaneni R, Birch ML, Hemmings HC Jr. Widespread inhibition of sodium channel-dependent glutamate release from isolated nerve terminals by isoflurane and propofol. Anesthesiology 2001;95:1460-6
9. Westphalen RI, Hemmings HC Jr. Selective depression by general anesthetics of glutamate versus GABA release from isolated cortical nerve terminals. J Pharmacol Exp Ther 2003;304: 1188-96
10. Wu XS, Sun JY, Evers AS, Crowder M, Wu LG. Isoflurane inhibits transmitter release and the presynaptic action potential. Anesthesiology 2004;100:663-70
11. Franks NP, Dickinson R, de Sousa SL, Hall AC, Lieb WR. How does xenon produce anaesthesia? Nature 1998;396:324
12. Martin DC, Plagenhoef M, Abraham J, Dennison RL, Aronstam RS. Volatile anesthetics and glutamate activation of N-methyld- aspartate receptors. Biochem Pharmacol 1995;49:809-17
13. Mihic SJ, Ye Q, Wick MJ, Koltchine VV, Krasowski MD, Finn SE, Mascia MP, Valenzuela CF, Hanson KK, Greenblatt EP, Harris RA, Harrison NL. Sites of alcohol and volatile anaesthetic action on GABA(A) and glycine receptors. Nature 1997;389:385-9
14. Franks NP. Molecular targets underlying general anaesthesia. Br J Pharmacol 2006;147(Suppl 1):S72-S81
15. Neal MJ, Robson JM. The analgesic and anaesthetic actions of tetrafluorobenzene. Br J Pharmacol Chemother 1966;26:482-93
16. Solt K, Eger EI 2nd, Raines DE. Differential modulation of human N-methyl-d-aspartate receptors by structurally diverse general anesthetics. Anesth Analg 2006;102:1407-11
17. Kelly EW, Solt K, Raines DE. Volatile aromatic anesthetics variably impact human gamma-aminobutyric acid type A receptor function. Anesth Analg 2007;105:1287-92
18. Catterall WA. From ionic currents to molecular mechanisms: the structure and function of voltage-gated sodium channels. Neuron 2000;26:13-25
19. Catterall WA, Goldin AL, Waxman SG. International Union of Pharmacology. XLVII. Nomenclature and structure-function relationships of voltage-gated sodium channels. Pharmacol Rev 2005;57:397-409
20. Goldin AL. Resurgence of sodium channel research. Annu Rev Physiol 2001;63:871-94
21. Antognini JF, Schwartz K. Exaggerated anesthetic requirements in the preferentially anesthetized brain. Anesthesiology 1993;79: 1244-9
22. Fang Z, Sonner J, Laster MJ, Ionescu P, Kandel L, Koblin DD, Eger EI II, Halsey MJ. Anesthetic and convulsant properties of aromatic compounds and cycloalkanes: implications for mechanisms of narcosis. Anesth Analg 1996;83:1097-104
23. Raines DE, Gioia F, Claycomb RJ, Stevens RJ. The N-methyl- daspartate receptor inhibitory potencies of aromatic inhaled drugs of abuse: evidence for modulation by cation-pi interactions. J Pharmacol Exp Ther 2004;311:14-21
24. Horishita T, Harris RA. n-Alcohols inhibit voltage-gated Na- channels expressed in Xenopus oocytes. J Pharmacol Exp Ther 2008;326:270-7
25. Koblin DD, Chortkoff BS, Laster MJ, Eger EI 2nd, Halsey MJ, Ionescu P. Polyhalogenated and perfluorinated compounds that disobey the Meyer-Overton hypothesis. Anesth Analg 1994;79: 1043-8
26. Ratnakumari L, Vysotskaya TN, Duch DS, Hemmings HC Jr. Differential effects of anesthetic and nonanesthetic cyclobutanes on neuronal voltage-gated sodium channels. Anesthesiology 2000;92:529-41